Edwards Cardioband European Post-Market Study, MiBAND
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Annuloplasty
- Edwards Cardioband
- Mitral Insufficiency
- Mitral Regurgitation
- Mitral Repair
- Mitral Valve
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
MiBAND is a prospective, single arm, European post-market study to assess the safety and efficacy of the Edwards Cardioband system. Patients will be followed up at 30D, 6months, 1, 2 and 3 years.
MiBAND is a prospective, single arm, European post-market study to assess the safety and efficacy of the Edwards Cardioband system. Patients will be followed up at 30D, 6months, 1, 2 and 3 years.
Tracking Information
- NCT #
- NCT03600688
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Stephan Baldus, MD Herzzentrum UniKlinik Köln Principal Investigator: Francesco Maisano, MD University Hospital, Zürich
Get Well Soon